These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 904079)

  • 1. [Fractionated transfusions and leukapheresis: Their application and problems in the therapy of leukemia. Platelet transfusion. a. Methods and efficacies (author's transl)].
    Iwanaga T; Amemiya Y
    Rinsho Ketsueki; 1977 May; 18(5):587-95. PubMed ID: 904079
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on blood component transfusion with continuous blood cell separator (IBM 2997). Part 2: methods of granulocyte and platelet harvesting and efficacies of the component transfusion].
    Toki H; Ishikawa M
    Rinsho Ketsueki; 1982 Apr; 23(4):441-8. PubMed ID: 7131790
    [No Abstract]   [Full Text] [Related]  

  • 3. [Leukapheresis of patients with acute leukemia and chronic myelogenous leukemia (author's transl)].
    Kawashima K; Ueda R
    Rinsho Ketsueki; 1977 May; 18(5):620-6. PubMed ID: 269295
    [No Abstract]   [Full Text] [Related]  

  • 4. [Factors affecting the results of platelet transfusions (author's transl)].
    Harada K; Adachi M
    Rinsho Ketsueki; 1977 May; 18(5):596-601. PubMed ID: 904080
    [No Abstract]   [Full Text] [Related]  

  • 5. [Replacement therapy with blood components in bone-marrow depression due to cytostatic drugs (author's transl)].
    Höcker P; Pittermann E; Mann M; Krasa E
    Wien Klin Wochenschr; 1980 Aug; 92(15):530-5. PubMed ID: 7001766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of leukocyte and platelet administration in cancer therapy.
    Walker EM; Cannon A; Mitchum EN
    Ann Clin Lab Sci; 1983; 13(6):453-73. PubMed ID: 6197928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood component therapy. Supportive therapy for acute leukemia (author's transl)].
    Maekawa I; Sakurada K; Shiraishi T
    Hokkaido Igaku Zasshi; 1977 Jul; 52(4):381-6. PubMed ID: 336501
    [No Abstract]   [Full Text] [Related]  

  • 8. Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized controlled trial with a sequential Bayesian design.
    Tinmouth A; Tannock IF; Crump M; Tomlinson G; Brandwein J; Minden M; Sutton D
    Transfusion; 2004 Dec; 44(12):1711-9. PubMed ID: 15584985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune and nonimmune causes of low recovery from leukodepleted platelet transfusions: a prospective study.
    Levin MD; de Veld JC; van der Holt B; van 't Veer MB
    Ann Hematol; 2003 Jun; 82(6):357-62. PubMed ID: 12719885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation.
    Gurkan E; Patah PA; Saliba RM; Ramos CA; Anderson BS; Champlin R; de Lima M; Lichtiger B
    Bone Marrow Transplant; 2007 Sep; 40(5):461-4. PubMed ID: 17589530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytapheresis therapy of adult T-cell leukemia: a case report (author's transl)].
    Imamura N; Tokumo K; Koganemaru S; Oguma N; Okada K; Kuramoto A
    Rinsho Ketsueki; 1981 Jun; 22(6):885-90. PubMed ID: 6977655
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet transfusions in 75 patients undergoing autologous bone marrow transplantation.
    Lund BV; Madsen M
    Transplant Proc; 1994 Jun; 26(3):1825. PubMed ID: 8030156
    [No Abstract]   [Full Text] [Related]  

  • 13. Review of definitions and mechanisms of refractoriness to platelet transfusions.
    Hester JP; Ventura GJ
    Prog Clin Biol Res; 1990; 337():49-58. PubMed ID: 2191338
    [No Abstract]   [Full Text] [Related]  

  • 14. Protein A column therapy for a patient refractory to platelet transfusions undergoing allogeneic hematopoietic stem cell transplantation.
    Laroche V; Hume HA; Moghrabi A; Duval M; Champagne J; Champagne MA
    Bone Marrow Transplant; 2005 Mar; 35(6):623-4. PubMed ID: 15640813
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic leukapheresis in hairy cell leukemia.
    Mielke CH; Dobbs CE; Winkler CF; Yam LT
    Arch Intern Med; 1982 Apr; 142(4):700-2. PubMed ID: 7073413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Donor peripheral stem cells infusion for the treatment of failure of platelet recovery after allogeneic hematopoietic stem cell transplantation].
    Chen Y; Xu LP; Liu DH; Chen YH; Han W; Shi HX; Zhang XH; Wang JZ; Chen H; Liu KY; Huang XJ; Lu DP
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):964-6. PubMed ID: 17650420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Methods of plasmapheresis using blood fractionation devices].
    Kalinin NN
    Sov Med; 1989; (8):40-5. PubMed ID: 2683140
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bone marrow transplantation in patients with acute leukemia and aplastic anemia (author's transl)].
    Yamada K
    Rinsho Ketsueki; 1980 Apr; 21(4):457-64. PubMed ID: 6997545
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ineffective platelet transfusion in patients with hematology malignancy].
    Chen S; Xiao L; Zou X
    Zhonghua Yi Xue Za Zhi; 1998 Nov; 78(11):824-6. PubMed ID: 11038776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation.
    Toor AA; Choo SY; Little JA
    Bone Marrow Transplant; 2000 Aug; 26(3):315-20. PubMed ID: 10967572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.